Published in Virulence on November 10, 2016
Geriatric-HIV medicine: A science in its infancy. Virulence (2017) 0.75
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab (1999) 10.64
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med (2013) 8.47
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab (2001) 7.53
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med (2011) 6.30
Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med (2010) 6.13
Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One (2014) 6.01
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab (2002) 4.46
Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med (2011) 4.38
Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab (2008) 3.67
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab (2006) 3.46
Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab (2004) 3.45
Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2010) 3.40
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci (2005) 3.14
The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev (2005) 3.11
Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med (2007) 2.88
Lifespan and testosterone. Nature (1993) 2.84
Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab (2004) 2.73
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med (2013) 2.65
Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2005) 2.63
Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc (2007) 2.63
Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract (2006) 2.49
Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res (2008) 2.44
Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med (1992) 2.43
Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab (2010) 2.28
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care (2002) 2.28
Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med (2007) 2.27
Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab (1991) 2.27
Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab (1983) 2.20
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care (2000) 2.18
Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab (2013) 2.11
Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab (2006) 2.08
Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res (1997) 2.03
Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab (2010) 2.01
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism (1997) 1.97
Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res (2006) 1.91
Free testosterone and risk for Alzheimer disease in older men. Neurology (2004) 1.88
Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol (1998) 1.86
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab (2013) 1.77
Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci (2005) 1.76
Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab (2002) 1.70
Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab (2007) 1.70
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract (2004) 1.69
Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol (2012) 1.65
Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study. Nutr Metab Cardiovasc Dis (2007) 1.62
Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study. Eur J Epidemiol (2009) 1.61
The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab (2006) 1.60
Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatr Soc (2011) 1.57
Hypogonadism in elderly men--what to do until the evidence comes. N Engl J Med (2004) 1.57
The relationships between sex hormones and sexual function in middle-aged and older European men. J Clin Endocrinol Metab (2011) 1.53
Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol (1997) 1.52
The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab (2009) 1.52
Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab (1999) 1.50
Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ (2015) 1.48
Cohort Profile: The Health In Men Study (HIMS). Int J Epidemiol (2008) 1.47
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf (2014) 1.44
Changes in the pituitary-testicular system with age. Clin Endocrinol (Oxf) (1976) 1.43
Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2006) 1.38
Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab (1999) 1.35
Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study. J Clin Endocrinol Metab (2004) 1.34
The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study. Eur J Endocrinol (2003) 1.33
The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl (2008) 1.33
Epididymitis and orchitis: an overview. Am Fam Physician (2009) 1.31
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31
Activities and attitudes of participants in the Baltimore longitudinal study. J Gerontol (1966) 1.30
Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol (Oxf) (2007) 1.30
An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol (1991) 1.28
Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab (1996) 1.26
Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab (2002) 1.26
Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab (2009) 1.23
The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol (2006) 1.20
Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab (2005) 1.19
Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol (2009) 1.19
The ability of three different models of frailty to predict all-cause mortality: results from the European Male Aging Study (EMAS). Arch Gerontol Geriatr (2013) 1.18
Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol (2010) 1.18
Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol (2013) 1.17
Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab (1985) 1.17
Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. Eur J Endocrinol (2004) 1.17
Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol (2012) 1.16
Cohort Profile: the Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol (2008) 1.15
Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab (1984) 1.15
Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study. J Clin Endocrinol Metab (2011) 1.15
Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab (2009) 1.14
Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med (2012) 1.13
Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab (2010) 1.13
Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc (2006) 1.13
Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab (1980) 1.12
Gonadal dysfunction in systemic diseases. Eur J Endocrinol (2005) 1.11
Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med (2006) 1.10
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol (2013) 1.10
Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol (2008) 1.10
Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med (2014) 1.10
Age-related frailty and its association with biological markers of ageing. BMC Med (2015) 1.09
A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol (2012) 1.09
Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am (2007) 1.09